Search Within

Elisa De Stanchina

  1. "Nagavarakishore Pillarsetty"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Radiochemistry and Imaging Sciences Service (8)
  2. Radiology, Department of (8)
  3. Sloan Kettering Institute Postdocs (8)
  4. Department of Medicine (5)
  5. Solid Tumor Oncology Division (5)
  6. GSK Faculty (3)

More Groups

People
  1. Nagavarakishore Pillarsetty (8)
  2. Teja Muralidhar Kalidindi (5)
  3. Daniel Danila (3)
  4. Deborah Fidele (3)
  5. Michael Morris (3)
  6. Philip Kantoff (3)

More People

Years
  1. 2025 (1)
  2. 2022 (2)
  3. 2021 (4)
  4. 2020 (1)
Publications
  1. Cancer Research (1)
  2. Cell Reports (1)
  3. Communications Biology (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Nuclear Medicine (1)
  6. Nature Communications (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)
  6. Society of Nuclear Medicine (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
    Journal Article

    Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration through the tumor
    Journal Article

    Russell, J.; Fanchon, L.; Alwaseem, H.; Molina, H.; O'Donoghue, I.; Bahr, A.; de Stanchina, E.; Pillarsetty, N.; Humm, J. L.
    Pharmacology Research & Perspectives (2022)

    Fulltext@MSK | Save
  • Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
    Journal Article

    Saha, N.; Xu, K.; Zhu, Z.; Robev, D.; Kalidindi, T.; Xu, Y.; Himanen, J.; de Stanchina, E.; Pillarsetty, N. V. K.; Dimitrov, D. S.; more...
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
    Journal Article

    Joshi, S.; Gomes, E. D.; Wang, T.; Corben, A.; Taldone, T.; Gandu, S.; Xu, C.; Sharma, S.; Buddaseth, S.; Yan, P.; more...
    Communications Biology (2021)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Predicting gemcitabine delivery by (18)F-FAC PET in murine models of pancreatic cancer
    Journal Article

    Russell, J.; Grkovski, M.; O'Donoghue, I. J.; Kalidindi, T. M.; Pillarsetty, N.; Burnazi, E. M.; Kulick, A.; Bahr, A.; Chang, Q.; LeKaye, H. C.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
    Journal Article

    Inda, M. C.; Joshi, S.; Wang, T.; Bolaender, A.; Gandu, S.; Koren, J. 3rd; Che, A. Y.; Taldone, T.; Yan, P.; Sun, W.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save